West Europe
United Kingdom· FromeModerna's mRNA Cancer Vaccine Shows Promising Results in Melanoma Trial
Moderna and Merck announced that a personalized mRNA cancer vaccine significantly reduced the risk of melanoma recurrence and spread in a late-stage trial, causing Moderna shares to soar.
Quorum · collective opinions
Moderna and Merck's mRNA cancer vaccine shows promise
First report 2h agoLast update 2h ago1 takes▲ 1
optimism for new treatmentpositiveShow 2 posts
started 2h ago•Last update 2h ago
The successful trial results of the mRNA cancer vaccine are raising new hope for melanoma treatment and boosting the healthcare sector.
iWitness comments
No comments yet — be the first to weigh in.